G. Pasquini

1.1k total citations
27 papers, 529 citations indexed

About

G. Pasquini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, G. Pasquini has authored 27 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 11 papers in Surgery. Recurrent topics in G. Pasquini's work include Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). G. Pasquini is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). G. Pasquini collaborates with scholars based in Italy, Malaysia and United States. G. Pasquini's co-authors include Giuseppe Giaccone, Alfredo Falcone, Enrico Vasile, Caterina Vivaldi, Chiara Caparello, Iacopo Petrini, Stefania Crucitta, Eleonora Rofi, Romano Danesi and Marzia Del Re and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

G. Pasquini

26 papers receiving 520 citations

Peers

G. Pasquini

ONCOL

PRM

SURGE

Delphine Topart France

Elisa Tassinari Italy

Jinpeng Shi China

Miaoyan Wei China

Vito Longo Italy

Guanghai Dai China

Alessio Fabozzi Italy

Ciro Longobardi Italy

Qiyun Ou China

Boyang Chang China

Delphine Topart France

G. Pasquini

425 ×1.4

ONCOL

122 ×0.6

234 ×1.2

PRM

231 ×1.4

52 ×0.4

SURGE

Citations per year, relative to G. Pasquini G. Pasquini (= 1×) peers Delphine Topart

Countries citing papers authored by G. Pasquini

Since Specialization

Citations

This map shows the geographic impact of G. Pasquini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Pasquini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Pasquini more than expected).

Fields of papers citing papers by G. Pasquini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Pasquini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Pasquini. The network helps show where G. Pasquini may publish in the future.

Co-authorship network of co-authors of G. Pasquini

This figure shows the co-authorship network connecting the top 25 collaborators of G. Pasquini. A scholar is included among the top collaborators of G. Pasquini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Pasquini. G. Pasquini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pasquini, G., C. Menichelli, F. Casamassima, et al.. (2021). Stereotactic body radiation therapy for the treatment of pleural metastases in patients with thymoma: a retrospective review of 22 patients. Journal of Thoracic Disease. 13(11). 6373–6380. 4 indexed citations

Vivaldi, Caterina, Lorenzo Fornaro, Clara Ugolini, et al.. (2020). HER2 Overexpression as a Poor Prognostic Determinant in Resected Biliary Tract Cancer. The Oncologist. 25(10). 886–893. 39 indexed citations

Re, Marzia Del, Federico Cucchiara, Eleonora Rofi, et al.. (2020). A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC. Cancer Immunology Immunotherapy. 70(6). 1667–1678. 28 indexed citations

Fornaro, Lorenzo, Caterina Vivaldi, Paola Orlandi, et al.. (2019). Longitudinal evaluation of angiogenesis-related circulating biomarkers during second-line treatment with paclitaxel and ramucirumab in advanced gastroesophageal cancer. Annals of Oncology. 30. iv88–iv88. 1 indexed citations

Pasquini, G., Liliane E. Petrini, Ramon Castellana, et al.. (2019). P1.15-10 Trabectedin Has Limited Clinical Activity in Pretreated Patients with Pleural Mesothelioma. Journal of Thoracic Oncology. 14(10). S583–S584.

Catanese, Silvia, Giacomo Aringhieri, Carla Cappelli, et al.. (2019). Baseline computed-tomography (CT)-evaluated sarcopenia predicts toxicity from first-line chemotherapy in metastatic gastric cancer (mGC) patients. Annals of Oncology. 30. iv82–iv82. 1 indexed citations

Vivaldi, Caterina, Lorenzo Fornaro, Carla Cappelli, et al.. (2019). Early Tumor Shrinkage and Depth of Response Evaluation in Metastatic Pancreatic Cancer Treated with First Line Chemotherapy: An Observational Retrospective Cohort Study. Cancers. 11(7). 939–939. 13 indexed citations

Re, Marzia Del, Riccardo Marconcini, G. Pasquini, et al.. (2018). PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC. British Journal of Cancer. 118(6). 820–824. 205 indexed citations

Dadduzio, Vincenzo, Mario Domenico Rizzato, Caterina Vivaldi, et al.. (2018). Advanced intrahepatic cholangiocarcinoma (iCCA) treated with arterial-directed therapies (ADT): Outcomes and safety from a multicenter Italian experience. Annals of Oncology. 29. viii261–viii261. 1 indexed citations

10.

Caparello, Chiara, Caterina Vivaldi, Francesca Montagnani, et al.. (2017). Second-line (SL) chemotherapy containing oxaliplatin (OXA) in metastatic pancreatic cancer (PC): Whom should we trust?. Journal of Clinical Oncology. 35(15_suppl). e15719–e15719. 1 indexed citations

11.

Vivaldi, Caterina, Enrico Vasile, Chiara Caparello, et al.. (2016). PD-022 FOLFOXIRI as primary treatment for locally advanced unresectable pancreatic cancer (LAPC): a prospective study. Annals of Oncology. 27. ii109–ii109. 1 indexed citations

12.

Pasquini, G., Enrico Vasile, Chiara Caparello, et al.. (2016). Third-Line Chemotherapy with Irinotecan plus 5-Fluorouracil in Caucasian Metastatic Gastric Cancer Patients. Oncology. 91(6). 311–316. 10 indexed citations

13.

Vivaldi, Caterina, Chiara Caparello, Gianna Musettini, et al.. (2016). First‐line treatment with FOLFOXIRI for advanced pancreatic cancer in clinical practice: Patients' outcome and analysis of prognostic factors. International Journal of Cancer. 139(4). 938–945. 30 indexed citations

14.

Fanotto, V., Caterina Fontanella, Mario Uccello, et al.. (2015). Impact of age, ECOG PS and type of treatment on progression-free survival and overall survival in second-line therapy for advanced gastric cancer: analysis on 709 cases. Annals of Oncology. 26. vi91–vi91. 1 indexed citations

15.

Fornaro, Lorenzo, Caterina Vivaldi, Stefano Cereda, et al.. (2015). Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: a multicenter survey and pooled analysis with published data. Journal of Experimental & Clinical Cancer Research. 34(1). 156–156. 49 indexed citations

16.

Musettini, Gianna, Chiara Caparello, Caterina Vivaldi, et al.. (2015). Palliative gastrectomy in asymptomatic metastatic esophagogastric cancer (EGC): does it make sense?. Annals of Oncology. 26. vi98–vi98. 1 indexed citations

17.

Pasquini, G., Lorenzo Fornaro, Enrico Vasile, et al.. (2015). Single-centre experience with third-line chemotherapy with irinotecan plus 5-fluorouracil and leucovorin (FOLFIRI) in metastatic gastric cancer patients. Annals of Oncology. 26. vi99–vi99. 9 indexed citations

18.

Fornaro, Lorenzo, Caterina Vivaldi, Giovanni Brandi, et al.. (2015). P-147 Outcome of second-line chemotherapy (CT2) after first-line CT (CT1) with platinum plus gemcitabine in advanced biliary tract cancer (aBTC): is it worthwhile?. Annals of Oncology. 26. iv42–iv42. 1 indexed citations

19.

Vivaldi, Caterina, Enrico Vasile, Lorenzo Fornaro, et al.. (2015). 2362 Second-line treatment after disease progression following first-line chemotherapy with modified FOLFIRINOX in advanced pancreatic cancer patients. European Journal of Cancer. 51. S456–S457. 1 indexed citations

20.

Schirripa, Marta, Sara Lonardi, Chiara Cremolini, et al.. (2014). Phase II Study of Single Agent Cetuximab in Kras G13D Mutant Metastatic Colorectal Cancer (MCRC). Annals of Oncology. 25. ii6–ii6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact